Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Alleged Pharma Influence : World Health Organisation calls for Discontinuation of two Publications

      Alleged Pharma Influence : World Health Organisation calls for Discontinuation of two Publications

      Medical Dialogues Bureau20 Jun 2019 1:37 PM IST
      The World Health Organization notified U.S. lawmakers Wednesday that it will discontinue two publications on prescribing opioid painkillers in...
      Caplin Points sterile injectable site in Chennai gets two USFDA observations

      Caplin Point's sterile injectable site in Chennai gets two USFDA observations

      Medical Dialogues Bureau20 Jun 2019 1:34 PM IST
      New Delhi: Caplin Point Laboratories Monday said the US health regulator has made two observations after completion of inspection at its subsidiary's...
      Glenmark Pharma gets tentative nod from USFDA for acne treatment drug

      Glenmark Pharma gets tentative nod from USFDA for acne treatment drug

      Medical Dialogues Bureau20 Jun 2019 1:33 PM IST
      New Delhi: Glenmark Pharmaceuticals Thursday it has received tentative approval from the US health regulator for Clindamycin Phosphate Foam, used to...
      Indian Pharma aspiring to grow to 120-130 billion Dollar Industry by 2030: IPA

      Indian Pharma aspiring to grow to 120-130 billion Dollar Industry by 2030: IPA

      Medical Dialogues Bureau20 Jun 2019 1:29 PM IST
      NEW DELHI: The Indian pharmaceutical industry is aspiring to touch USD 120-130 billion by 2030 from the current USD 38 billion, industry body Indian...
      AstraZenecas Lynparza gets EU nod as first-line ovarian cancer maintenance treatment

      AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment

      Medical Dialogues Bureau19 Jun 2019 12:02 PM IST
      British drugmaker AstraZeneca Plc on Tuesday said its cancer medicine Lynparza was approved as a first-line maintenance treatment for a type of...
      Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH

      Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH

      Medical Dialogues Bureau19 Jun 2019 12:01 PM IST
      AHMEDABAD: Zydus Cadila, an innovation-driven, global pharmaceutical company, announced that it has completed enrolment of 104 patients with...
      Roche wins Japan approval for personalised cancer drug Rozlytrek

      Roche wins Japan approval for personalised cancer drug Rozlytrek

      Medical Dialogues Bureau19 Jun 2019 12:01 PM IST
      ZURICH: Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalised...
      Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan

      Yet another Cancer Causing impurity flagged in blood pressure drug Valsartan

      Medical Dialogues Bureau19 Jun 2019 12:01 PM IST
      Online pharmacy Valisure reported that it found a new cancer-causing impurity in some versions of widely prescribed blood pressure medicine valsartan,...
      Sanofi to Partner with Google to use AI, Deep Analytics to find better treatments

      Sanofi to Partner with Google to use AI, Deep Analytics to find better treatments

      Medical Dialogues Bureau19 Jun 2019 11:58 AM IST
      PARIS: French pharmaceutical firm Sanofi said Tuesday it is partnering with Google to use artificial intelligence and deep analytics tools to sift...
      GSK pharma head flags need for speed in high-pressure drug market

      GSK pharma head flags need for speed in high-pressure drug market

      Medical Dialogues Bureau18 Jun 2019 2:06 PM IST
      LONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
      Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

      Cadila Healthcare gets EIR report on Ahmedabad SEZ facility

      Medical Dialogues Bureau18 Jun 2019 1:57 PM IST
      New Delhi: Drug firm Cadila Healthcare Monday said it has received establishment inspection report from the US health regulator with voluntary action...
      Pfizer to buy cancer drug developer Array for 10.64 billion Dollars

      Pfizer to buy cancer drug developer Array for 10.64 billion Dollars

      Medical Dialogues Bureau18 Jun 2019 1:47 PM IST
      Pfizer Inc said on Monday it would acquire Array Biopharma Inc for $10.64 billion in cash, giving it access to the target's approved drugs for skin...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok